183 related articles for article (PubMed ID: 38155245)
1. Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL.
Parriott G; Hegermiller E; Morman RE; Frank C; Saygin C; Stock W; Bartom ET; Kee BL
Leukemia; 2024 Mar; 38(3):491-501. PubMed ID: 38155245
[TBL] [Abstract][Full Text] [Related]
2. Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T lymphocyte acute lymphoblastic leukemia.
Parriott G; Hegermiller E; Morman RE; Frank C; Saygin C; Stock W; Bartom ET; Kee BL
bioRxiv; 2023 Apr; ():. PubMed ID: 37163059
[TBL] [Abstract][Full Text] [Related]
3. E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia.
Parriott G; Kee BL
Front Immunol; 2022; 13():885144. PubMed ID: 35514954
[TBL] [Abstract][Full Text] [Related]
4. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice.
Smith KS; Rhee JW; Naumovski L; Cleary ML
Mol Cell Biol; 1999 Jun; 19(6):4443-51. PubMed ID: 10330184
[TBL] [Abstract][Full Text] [Related]
5. The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance.
O'Connor KW; Kishimoto K; Kuzma IO; Wagner KP; Selway JS; Roderick JE; Karna KK; Gallagher KM; Hu K; Liu H; Li R; Brehm MA; Zhu LJ; Curtis DJ; Tremblay CS; Kelliher MA
Leukemia; 2024 May; 38(5):951-962. PubMed ID: 38553571
[TBL] [Abstract][Full Text] [Related]
6. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.
Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP
Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838
[TBL] [Abstract][Full Text] [Related]
7. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
Sykes DB; Kamps MP
Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in
Carr T; McGregor S; Dias S; Verykokakis M; Le Beau MM; Xue HH; Sigvardsson M; Bartom ET; Kee BL
Front Immunol; 2022; 13():845488. PubMed ID: 35371057
[TBL] [Abstract][Full Text] [Related]
9. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
[TBL] [Abstract][Full Text] [Related]
10. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract][Full Text] [Related]
11. E2A proteins enforce a proliferation checkpoint in developing thymocytes.
Engel I; Murre C
EMBO J; 2004 Jan; 23(1):202-11. PubMed ID: 14685278
[TBL] [Abstract][Full Text] [Related]
12. Notch3 is dispensable for thymocyte β-selection and Notch1-induced T cell leukemogenesis.
Suliman S; Tan J; Xu K; Kousis PC; Kowalski PE; Chang G; Egan SE; Guidos C
PLoS One; 2011; 6(9):e24937. PubMed ID: 21931869
[TBL] [Abstract][Full Text] [Related]
13. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor-negative thymocytes from SCID mice can be induced to enter the CD4/CD8 differentiation pathway.
Shores EW; Sharrow SO; Uppenkamp I; Singer A
Eur J Immunol; 1990 Jan; 20(1):69-77. PubMed ID: 1968394
[TBL] [Abstract][Full Text] [Related]
15. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.
Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H
Blood; 1999 May; 93(9):2780-90. PubMed ID: 10216071
[TBL] [Abstract][Full Text] [Related]
16. E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression.
Wojciechowski J; Lai A; Kondo M; Zhuang Y
J Immunol; 2007 May; 178(9):5717-26. PubMed ID: 17442955
[TBL] [Abstract][Full Text] [Related]
17. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas.
Bain G; Engel I; Robanus Maandag EC; te Riele HP; Voland JR; Sharp LL; Chun J; Huey B; Pinkel D; Murre C
Mol Cell Biol; 1997 Aug; 17(8):4782-91. PubMed ID: 9234734
[TBL] [Abstract][Full Text] [Related]
18. The Role of TAL1 in Hematopoiesis and Leukemogenesis.
Vagapova ER; Spirin PV; Lebedev TD; Prassolov VS
Acta Naturae; 2018; 10(1):15-23. PubMed ID: 29713515
[TBL] [Abstract][Full Text] [Related]
19. Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.
Li L; Mitra A; Cui K; Zhao B; Choi S; Lee JY; Stamos DB; El-Khoury D; Warzecha C; Pfeifer K; Hardwick J; Zhao K; Venters B; Davé UP; Love PE
Blood; 2020 Jun; 135(25):2252-2265. PubMed ID: 32181817
[TBL] [Abstract][Full Text] [Related]
20. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
